Anifrolumab modulates key immune pathways in patients with systemic lupus erythematosus (SLE)
7:39
Anifrolumab modulates key immune pathways in patients with systemic lupus erythematosus (SLE)
6.5K viewsMay 21, 2024
YouTubeAnnals of the Rheumatic Diseases
See more